OC 56.5 In vitro and in vivo Amelioration of the von Willebrand Disease Type 2B Phenotype Using an Allele-specific siRNA
- DOI
- 10.1002/rth2.12227
- Published
- 2019-07
- Container
- Research and Practice in Thrombosis and Haemostasis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/rth2.12227,
title = {OC 56.5 In vitro and in vivo Amelioration of the von Willebrand Disease Type 2B Phenotype Using an Allele-specific siRNA},
author = {A De Jong and C Casari and R.J. Dirven and B.J.M. Van Vlijmen and P.J. Lenting and C.V. Denis and J. Eikenboom},
year = {2019},
journal = {Research and Practice in Thrombosis and Haemostasis},
doi = {10.1002/rth2.12227},
url = {https://doi.org/10.1002/rth2.12227}
}RIS
TY - JOUR TI - OC 56.5 In vitro and in vivo Amelioration of the von Willebrand Disease Type 2B Phenotype Using an Allele-specific siRNA AU - A De Jong AU - C Casari AU - R.J. Dirven AU - B.J.M. Van Vlijmen AU - P.J. Lenting AU - C.V. Denis AU - J. Eikenboom PY - 2019 JO - Research and Practice in Thrombosis and Haemostasis DO - 10.1002/rth2.12227 UR - https://doi.org/10.1002/rth2.12227 ER -
APA
Jong, A. D., Casari, C., Dirven, R., Vlijmen, B. V., Lenting, P., Denis, C., & Eikenboom, J. (2019). OC 56.5 In vitro and in vivo Amelioration of the von Willebrand Disease Type 2B Phenotype Using an Allele-specific siRNA. Research and Practice in Thrombosis and Haemostasis. https://doi.org/10.1002/rth2.12227
Source records
- hal · retrieved 2026-09-26T05:55:21.445Z